z-logo
open-access-imgOpen Access
Inhaled iloprost as third add‐on therapy in idiopathic pulmonary arterial hypertension
Author(s) -
Fernandes Caio J.C.S.,
Silva Taysa A.F.,
Alves Jose L.,
Jardim Carlos V.P.,
Souza Rogerio
Publication year - 2021
Publication title -
pulmonary circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.791
H-Index - 40
ISSN - 2045-8940
DOI - 10.1177/2045894020981350
Subject(s) - medicine , iloprost , pulmonary hypertension , pharmacotherapy , cardiology , intensive care medicine , prostacyclin
Triple combination therapy is suggested in current pulmonary arterial hypertension guidelines in case of unsatisfactory treatment with oral double combination therapy. However, there is a lack of evidence concerning some of the drug combinations currently employed. We demonstrate the clinical and hemodynamical benefits of inhaled iloprost as third add‐on therapy in idiopathic pulmonary arterial hypertension.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here